Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Targeting Oral Cancer

BuchGebunden
302 Seiten
Englisch
Springererschienen am14.03.20161st ed. 2016
This book provides research-oriented care providers with up-to-date information on the oral cancer patient population, the ways in which we are treating them, and the scientific approaches being pursued in order to improve survival and reduce treatment-related morbidity.mehr
Verfügbare Formate
BuchGebunden
EUR106,99
BuchKartoniert, Paperback
EUR160,49
E-BookPDF1 - PDF WatermarkE-Book
EUR96,29

Produkt

KlappentextThis book provides research-oriented care providers with up-to-date information on the oral cancer patient population, the ways in which we are treating them, and the scientific approaches being pursued in order to improve survival and reduce treatment-related morbidity.
Zusammenfassung
Provides up-to-date information on the oral cancer patient population and treatment options

Examines the value of a variety of biomarkers

Describes breaking developments and new drug discoveries
Details
ISBN/GTIN978-3-319-27645-8
ProduktartBuch
EinbandartGebunden
Verlag
Erscheinungsjahr2016
Erscheinungsdatum14.03.2016
Auflage1st ed. 2016
Seiten302 Seiten
SpracheEnglisch
Gewicht786 g
IllustrationenX, 302 p. 38 illus., 2 illus. in color.
Artikel-Nr.36229856
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
Epidemiology and Management: Epidemiology.- Emerging Role of HPV.- Management of Oral Cancer. Development and Biomarkers: Molecular Progression and Signaling.- Stem Cells and Tumor Development.- Prognostic/Predictive Biomarkers.- EIF4e as Biomarker and Target. Breaking Developments and New Drug Discovery: Current Clinical Trials.- Emerging Drug Targets.- Targeting the UPR.- Targeting Meditators of Coagulation.- Resveratrol Pre-Sensitizing.- Academic High Throughput Drug Discovery.mehr
Kritik
"This title is useful in extending knowledge of the key aspects of the disease and would be ideal for those undertaking specific research at postgraduate level. Overall, this book is an informative read for those involved with oral cancers wishing to obtain up-to-date, well researched information. It is indeed a targeted resource to all aspects of this disease." (C. Whyte, British Dental Journal, Vol. 221 (8), October, 2016)mehr

Autor

Andrew M. Fribley graduated with a BS from Central Michigan University, Mt. Pleasant, MI and in 2005 gained his PhD from the University of Michigan, Ann Arbor, MI (Program in Oral Health Sciences, University of Michigan School of Dentistry). He then worked as a Post-Doctoral Research Fellow in the University of Michigan, School of Medicine, Department of Biological Chemistry and the Howard Hughes Medical Institute In 2010, Dr. Fribley was appointed Assistant Professor of Pediatrics at Wayne State University (Division of Hematology/Oncology), Detroit, MI. He is also an Associate in the Department of Otolaryngology at Wayne State University and a Scientific Member of the Karmanos Cancer Institute (Molecular Therapeutics Program). Dr. Fribley has received various awards, including the William J. Gies Award for the most outstanding manuscript published in the Journal of Dental Research (2003) and the Edward Hatton Award (First Prize, Senior Category) from the American Association of DentalResearch and the International Association of Dental Research (2004). Since 2012 he has been a member of the Fellowships Committee of the American Association of Dental Research. He has published original articles in a variety of leading peer-reviewed journals.
Weitere Artikel von
Herausgegeben von Fribley, Andrew